Skip to main content
OpenTrials
Completed

NCT Number: NCT01186965

Ehealth: Second Life Impacts Diabetes Education & Self-Management

The purpose of this study is to to develop and evaluate the feasibility, usability, and effect of participation in SLIDES (a virtual diabetes community in Second Life) for providing interactive diabetes education, support, and resources.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Duke University Medical Center

Durham, North Carolina, 27710, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • current Duke Endocrinology patient
  • are between 21 and 75 years old
  • are able to speak and read English
  • are computer literate (have used a computer for at least 6 months)
  • understand how to use the Internet (have accessed the Internet on at least 6 occasions)
  • have access to a computer with a non-dial-up Internet connection in a private location (home)
  • are mentally capable of informed consent
  • are reachable by telephone
  • have no pre-existing medical condition(s) or severe diabetes related complications that would interfere with study participation (i.e., physical activity) or measures (e.g., renal failure, Stage III hypertension, severe orthopedic conditions or joint replacement scheduled within 6 months, paralysis, bleeding disorders, cancer, or receipt of pharmacologic doses of anti-coagulant medications [warfarin])
  • are able to travel to Duke University Medical Center (DUMC) for follow-up appointments.

Exclusion criteria

-

Treatment and study plan

eHealth program in the Virtual Environment (VE) platform Second Life

Behavioral

determine the feasibility and acceptability of an eHealth program that provides diabetes education and self-management support.

Other names: Second Life

Primary outcomes

  1. Perceived Usefulness

    Time frame: 3 and 6 months

  2. Perceived Ease of Use

    Time frame: 3 and 6 months

  3. Process data

    Time frame: January 2011 through May 2012

Secondary outcomes

  1. Demographics

    Time frame: baseline

  2. Metabolic Indicators

    Time frame: baseline, 3 months, 6 months

  3. Diabetes knowledge

    Time frame: baseline, 3 months, 6 months

Sponsors and collaborators

Lead sponsor

Duke University

Other

Registry information

Acronym: SLIDES

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Aug 23, 2010
Registry last updated
Mar 6, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.